NUCLEOLIN and gastric cancer: In summary, this study addressed the development of a novel combined therapeutic strategy composed of AS1411 aptamer )aptNCL( and let-7d miRNA that can be used to target the gastric cancer cells with overexpression of nucleolin on their cell surface.